Bifogade filer
Kalender
Tid* | ||
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-15 | - | X-dag halvårsutdelning NOVO B 3.5 |
2024-08-07 | - | Kvartalsrapport 2024-Q2 |
2024-05-02 | - | Kvartalsrapport 2024-Q1 |
2024-03-22 | - | X-dag halvårsutdelning NOVO B 6.4 |
2024-03-21 | - | Årsstämma |
2024-01-31 | - | Bokslutskommuniké 2023 |
2023-11-02 | - | Kvartalsrapport 2023-Q3 |
2023-09-13 | - | Split NOVO B 1:2 |
2023-08-18 | - | X-dag halvårsutdelning NOVO B 6 |
2023-08-10 | - | Kvartalsrapport 2023-Q2 |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-03-24 | - | X-dag halvårsutdelning NOVO B 8.15 |
2023-03-23 | - | Årsstämma |
2023-02-01 | - | Bokslutskommuniké 2022 |
2022-11-02 | - | Kvartalsrapport 2022-Q3 |
2022-08-12 | - | X-dag halvårsutdelning NOVO B 4.25 |
2022-08-04 | - | Kvartalsrapport 2022-Q2 |
2022-05-04 | - | Kvartalsrapport 2022-Q1 |
2022-03-25 | - | X-dag halvårsutdelning NOVO B 6.9 |
2022-03-24 | - | Årsstämma |
2022-02-02 | - | Bokslutskommuniké 2021 |
2021-11-03 | - | Kvartalsrapport 2021-Q3 |
2021-08-16 | - | X-dag halvårsutdelning NOVO B 3.5 |
2021-08-05 | - | Kvartalsrapport 2021-Q2 |
2021-05-05 | - | Kvartalsrapport 2021-Q1 |
2021-03-26 | - | X-dag halvårsutdelning NOVO B 5.85 |
2021-03-25 | - | Årsstämma |
2021-02-03 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-08-14 | - | X-dag halvårsutdelning NOVO B 3.25 |
2020-08-06 | - | Kvartalsrapport 2020-Q2 |
2020-05-06 | - | Kvartalsrapport 2020-Q1 |
2020-03-27 | - | X-dag halvårsutdelning NOVO B 5.35 |
2020-03-26 | - | Årsstämma |
2020-02-05 | - | Bokslutskommuniké 2019 |
2019-11-01 | - | Kvartalsrapport 2019-Q3 |
2019-08-21 | - | Kvartalsrapport 2019-Q2 |
2019-08-16 | - | X-dag halvårsutdelning NOVO B 3 |
2019-05-03 | - | Kvartalsrapport 2019-Q1 |
2019-03-22 | - | X-dag halvårsutdelning NOVO B 5.15 |
2019-03-21 | - | Årsstämma |
2019-02-01 | - | Bokslutskommuniké 2018 |
2018-08-18 | - | X-dag halvårsutdelning NOVO B 3 |
2018-08-08 | - | Kvartalsrapport 2018-Q2 |
2018-05-02 | - | Kvartalsrapport 2018-Q1 |
2018-03-23 | - | X-dag halvårsutdelning NOVO B 4.85 |
2018-03-22 | - | Årsstämma |
2018-02-01 | - | Bokslutskommuniké 2017 |
2017-11-01 | - | Kvartalsrapport 2017-Q3 |
2017-08-18 | - | X-dag halvårsutdelning NOVO B 3 |
2017-08-09 | - | Kvartalsrapport 2017-Q2 |
2017-05-03 | - | Kvartalsrapport 2017-Q1 |
2017-03-24 | - | X-dag ordinarie utdelning NOVO B 4.60 DKK |
2017-03-23 | - | Årsstämma |
2017-02-02 | - | Bokslutskommuniké 2016 |
2016-10-28 | - | Kvartalsrapport 2016-Q3 |
2016-08-12 | - | X-dag halvårsutdelning NOVO B 3 |
2016-08-05 | - | Kvartalsrapport 2016-Q2 |
2016-04-29 | - | Kvartalsrapport 2016-Q1 |
2016-03-21 | - | X-dag halvårsutdelning NOVO B 6.4 |
2016-03-18 | - | Årsstämma |
2016-02-03 | - | Bokslutskommuniké 2015 |
2015-10-29 | - | Kvartalsrapport 2015-Q3 |
2015-08-06 | - | Kvartalsrapport 2015-Q2 |
2015-04-30 | - | Kvartalsrapport 2015-Q1 |
2015-03-20 | - | X-dag ordinarie utdelning NOVO B 5.00 DKK |
2015-03-19 | - | Årsstämma |
2015-01-30 | - | Bokslutskommuniké 2014 |
2014-10-30 | - | Kvartalsrapport 2014-Q3 |
2014-08-07 | - | Kvartalsrapport 2014-Q2 |
2014-05-01 | - | Kvartalsrapport 2014-Q1 |
2014-03-21 | - | X-dag ordinarie utdelning NOVO B 4.50 DKK |
2014-03-20 | - | Årsstämma |
2014-02-03 | - | Bokslutskommuniké 2013 |
2014-01-02 | - | Split NOVO B 1:5 |
2013-10-31 | - | Kvartalsrapport 2013-Q3 |
2013-08-08 | - | Kvartalsrapport 2013-Q2 |
2013-05-01 | - | Kvartalsrapport 2013-Q1 |
2013-03-21 | - | X-dag ordinarie utdelning NOVO B 18.00 DKK |
2013-03-20 | - | Årsstämma |
2013-02-04 | - | Bokslutskommuniké 2012 |
2012-10-31 | - | Kvartalsrapport 2012-Q3 |
2012-08-09 | - | Kvartalsrapport 2012-Q2 |
2012-04-27 | - | Kvartalsrapport 2012-Q1 |
2012-03-22 | - | X-dag ordinarie utdelning NOVO B 14.00 DKK |
2012-03-21 | - | Årsstämma |
2012-02-02 | - | Bokslutskommuniké 2011 |
2011-10-27 | - | Kvartalsrapport 2011-Q3 |
2011-08-04 | - | Kvartalsrapport 2011-Q2 |
2011-04-28 | - | Kvartalsrapport 2011-Q1 |
2011-03-24 | - | X-dag ordinarie utdelning NOVO B 10.00 DKK |
2011-03-23 | - | Årsstämma |
2011-02-02 | - | Bokslutskommuniké 2010 |
2010-03-25 | - | X-dag ordinarie utdelning NOVO B 7.50 DKK |
2007-12-03 | - | Split NOVO B 1:2 |
2001-04-04 | - | Split NOVO B 1:5 |
1997-01-02 | - | Split NOVO B 1:2 |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
Please find below a statement of such trading in shares issued by Novo Nordisk (see pdf-file for proper format).
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name of the Board member/Executive/Associated Person
Novo Holdings A/S, associated to Kasim Kutay
2
Reason for the notification
a)
Position/status
Member of the Board of Directors
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer
a)
Name
Novo Nordisk A/S
b)
LEI
549300DAQ1CVT6CXN342
4
Details of the transaction(s)
a)
Description of the financial instrument, type of instrument,
Identification code
Shares
Novo Nordisk B DK0062498333
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s) | Volume(s) |
DKK 750.42 | 6,311,250 shares |
d)
Aggregated information
- Aggregated volume
- Price
6,311,250 shares
DKK 4,736,088,225.00
e)
Date of the transaction
2024-11-08
f)
Place of the transaction
Outside a trading venue
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 72,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
Contacts for further information
Media: | |
Ambre James-Brown +45 3079 9289 abmo@novonordisk.com | Liz Skrbkova (US) +1 609 917 0632 lzsk@novonordisk.com |
Investors: | |
Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com | David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com |
Sina Meyer +45 3079 6656 azey@novonordisk.com | Ida Schaap Melvold +45 3077 5649 idmg@novonordisk.com |
Frederik Taylor Pitter +1 609 613 0568 fptr@novonordisk.com |
Company announcement No 86 / 2024